FOTIVDA
Generic: Tivozanib
- Manufacturer
- AVEO
- NDC
- 45629-089
- RxCUI
- 2534238
- Route
- ORAL
- ICD-10 indication
- C64.9
Affordability Check
How much will you actually pay for FOTIVDA?
In 30 seconds, see every legitimate way to afford FOTIVDA — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About FOTIVDA
What is this medication? FOTIVDA is a prescription medication that contains the active ingredient tivozanib. It is used to treat adults with advanced renal cell carcinoma, which is a common type of kidney cancer. This treatment is specifically intended for patients whose cancer has returned or has stopped responding to previous treatments after they have already received two or more other systemic therapies for their condition.
The medication belongs to a class of drugs known as kinase inhibitors. It works by targeting and blocking specific proteins called vascular endothelial growth factor receptors that are found on the surface of certain cells. By inhibiting these receptors, the drug helps to restrict the blood supply to the tumor and interferes with the signaling processes that allow cancer cells to grow and divide, thereby helping to slow the progression of the disease.
Copay & patient assistance
- Patient Copay Amount: As little as $0
- Maximum Annual Benefit Limit: $25,000 per calendar year
- Core Eligibility Restrictions: Patients must have commercial or private insurance; not valid for patients covered by any federal, state, or government-funded insurance program (including Medicare, Medicaid, TRICARE, Department of Defense, or Veterans Affairs); must be 18 years of age or older; must be a resident of the United States, Puerto Rico, or Guam; must be prescribed FOTIVDA for an FDA-approved indication.
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Tivozanib.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup FOTIVDA →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Tivozanib →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How FOTIVDA appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
43%
2,383 of 5,499 plans
Most common tier
Tier 5
On 79% of covering formularies
Prior authorization required
99%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 59 | 18% |
| Tier 2 (generic) | 2 | 1% |
| Tier 4 (non-preferred brand) | 7 | 2% |
| Tier 5 (specialty) | 259 | 79% |
| Tier 6 | 1 | 0% |
Step therapy: 0% of formularies
Quantity limits: 88% of formularies
Coverage breadth: 328 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
EVEROLIMUS
Treats same condition · Everolimus
AVMAPKI FAKZYNJA CO-PACK
Treats same condition · avutometinib potassium and defactinib hydrochloride
Fludeoxyglucose F18
Treats same condition · Fludeoxyglucose F18
Portrazza
Treats same condition · necitumumab
Pilocarpine Hydrochloride
Treats same condition · Pilocarpine Hydrochloride
TEPADINA
Treats same condition · THIOTEPA
AVGEMSI
Treats same condition · Gemcitabine
CLENPIQ
Treats same condition · SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
Niva Thyroid
Treats same condition · thyroid, porcine
Kisunla
Treats same condition · donanemab-azbt
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.